• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物风险工具给药方法的比较。

A comparison of methods of administering the opioid risk tool.

作者信息

Jones Ted, Passik Steven D

机构信息

Behavioral Medicine Institute at Pain Consultants of East Tennessee, Knoxville, Tennessee, USA.

出版信息

J Opioid Manag. 2011 Sep-Oct;7(5):347-51. doi: 10.5055/jom.2011.0075.

DOI:10.5055/jom.2011.0075
PMID:22165033
Abstract

Risk assessment and stratification have become important aspects for the prescription of opioids to patients with chronic pain. Recent research has shown that the Opioid Risk Tool (ORT), a widely used risk assessment tool, has poor predictive abilities when compared with other risk assessment methods. This study compares two different methods of administration of the ORT to further study this issue. Patients at a pain practice were given an ORT to complete per the usual method of administration. In addition, a separate blinded ORT was completed by a psychologist after conducting a clinical interview with the patient. The results of the patient-completed ORT (PC-ORT) and the clinician-completed ORT (CC-ORT) were compared. There were significant differences found between the two, with the psychologist usually rating the patient higher in risk. The CC-ORT demonstrated better prediction of aberrant drug-taking behavior than the PC-ORT. The items that were discrepant between the two suggest that the differences were primarily due to comprehension issues. A strategy to help maximize the usefulness of the ORT derived from this finding and clinical experience is discussed.

摘要

风险评估与分层已成为慢性疼痛患者阿片类药物处方的重要方面。最近的研究表明,与其他风险评估方法相比,广泛使用的风险评估工具阿片类药物风险评估表(ORT)的预测能力较差。本研究比较了ORT的两种不同施测方法,以进一步研究此问题。疼痛科的患者按照常规施测方法完成一份ORT。此外,心理学家在对患者进行临床访谈后,独立完成一份盲法ORT。比较了患者完成的ORT(PC-ORT)和临床医生完成的ORT(CC-ORT)的结果。发现两者之间存在显著差异,心理学家通常对患者的风险评级更高。CC-ORT在异常药物使用行为预测方面比PC-ORT表现更好。两者之间存在差异的项目表明,差异主要是由于理解问题。本文讨论了基于这一发现和临床经验来帮助最大化ORT效用的策略。

相似文献

1
A comparison of methods of administering the opioid risk tool.阿片类药物风险工具给药方法的比较。
J Opioid Manag. 2011 Sep-Oct;7(5):347-51. doi: 10.5055/jom.2011.0075.
2
Usefulness of the opioid risk tool to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain.阿片类药物风险工具在预测接受阿片类药物治疗慢性疼痛患者的异常药物相关行为方面的效用。
J Opioid Manag. 2013 May-Jun;9(3):177-87. doi: 10.5055/jom.2013.0159.
3
Preliminary data on a new opioid risk assessment measure: the Brief Risk Interview.一种新型阿片类药物风险评估方法的初步数据:简要风险访谈。
J Opioid Manag. 2013 Jan-Feb;9(1):19-27. doi: 10.5055/jom.2013.0143.
4
A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.比较常见的筛查方法,以预测接受阿片类药物治疗慢性疼痛管理的患者中异常药物相关行为。
Pain Med. 2009 Nov;10(8):1426-33. doi: 10.1111/j.1526-4637.2009.00743.x.
5
Validation of a new risk assessment tool: the Brief Risk Questionnaire.一种新的风险评估工具的验证:简易风险问卷。
J Opioid Manag. 2015 Mar-Apr;11(2):171-83. doi: 10.5055/jom.2015.0266.
6
Characteristics of chronic noncancer pain patients assessed with the opioid risk tool in a Canadian tertiary care pain clinic.在加拿大一家三级护理疼痛诊所使用阿片类药物风险工具评估的慢性非癌性疼痛患者的特征。
Pain Med. 2014 Oct;15(10):1743-9. doi: 10.1111/pme.12465. Epub 2014 May 16.
7
Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.阿片类药物依从性检查表在基层医疗中监测接受阿片类药物治疗的慢性疼痛患者的疗效。
J Pain. 2016 Apr;17(4):414-23. doi: 10.1016/j.jpain.2015.12.004. Epub 2015 Dec 17.
8
Development of the Revised Opioid Risk Tool to Predict Opioid Use Disorder in Patients with Chronic Nonmalignant Pain.修订后的阿片类药物风险工具的开发,以预测慢性非恶性疼痛患者的阿片类药物使用障碍。
J Pain. 2019 Jul;20(7):842-851. doi: 10.1016/j.jpain.2019.01.011. Epub 2019 Jan 26.
9
Further validation of an opioid risk assessment tool: the Brief Risk Interview.阿片类药物风险评估工具的进一步验证:简短风险访谈
J Opioid Manag. 2014 Sep-Oct;10(5):353-64. doi: 10.5055/jom.2014.0226.
10
Re-assessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population.重新评估阿片类药物风险工具在三级学术疼痛管理中心人群中的有效性。
Pain Med. 2018 Jul 1;19(7):1382-1395. doi: 10.1093/pm/pnx332.

引用本文的文献

1
Application of risk assessment tools to predict opioid usage after shoulder surgery.应用风险评估工具预测肩部手术后的阿片类药物使用情况。
JSES Int. 2022 Jul 3;6(5):833-842. doi: 10.1016/j.jseint.2022.06.001. eCollection 2022 Sep.
2
Diagnostic and Predictive Capacity of the Spanish Versions of the Opioid Risk Tool and the Screener and Opioid Assessment for Patients with Pain-Revised: A Preliminary Investigation in a Sample of People with Noncancer Chronic Pain.阿片类药物风险工具西班牙语版本以及疼痛患者筛查与阿片类药物评估修订版的诊断和预测能力:对非癌性慢性疼痛患者样本的初步调查
Pain Ther. 2022 Jun;11(2):493-510. doi: 10.1007/s40122-022-00356-2. Epub 2022 Feb 7.
3
Pain Management in Oncology Patients Amidst the Opioid Epidemic: How To Minimize Non-Medical Opioid Use.
阿片类药物流行背景下肿瘤患者的疼痛管理:如何尽量减少非医疗用途阿片类药物的使用。
Cureus. 2021 Nov 12;13(11):e19500. doi: 10.7759/cureus.19500. eCollection 2021 Nov.
4
Stories to Communicate Individual Risk for Opioid Prescriptions for Back and Kidney Stone Pain: Protocol for the Life STORRIED Multicenter Randomized Clinical Trial.用于传达背部和肾结石疼痛阿片类药物处方个体风险的故事:生命STORRIED多中心随机临床试验方案
JMIR Res Protoc. 2020 Sep 24;9(9):e19496. doi: 10.2196/19496.
5
Development of the Revised Opioid Risk Tool to Predict Opioid Use Disorder in Patients with Chronic Nonmalignant Pain.修订后的阿片类药物风险工具的开发,以预测慢性非恶性疼痛患者的阿片类药物使用障碍。
J Pain. 2019 Jul;20(7):842-851. doi: 10.1016/j.jpain.2019.01.011. Epub 2019 Jan 26.
6
Re-assessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population.重新评估阿片类药物风险工具在三级学术疼痛管理中心人群中的有效性。
Pain Med. 2018 Jul 1;19(7):1382-1395. doi: 10.1093/pm/pnx332.
7
Frontline Account: Reducing the Stress of Pain Management Through the Implementation of a Controlled Substance Review Group in a VA Internal Medicine Residency Clinic.一线报道:通过在退伍军人事务部内科住院医师诊所设立受控物质审查小组来减轻疼痛管理的压力
J Gen Intern Med. 2017 Jul;32(7):832-835. doi: 10.1007/s11606-016-3930-9.
8
Impact of an Electronic Pain and Opioid Risk Assessment Program: Are There Improvements in Patient Encounters and Clinic Notes?电子疼痛与阿片类药物风险评估项目的影响:患者诊疗过程及病历记录是否有所改善?
Pain Med. 2016 Nov;17(11):2047-2060. doi: 10.1093/pm/pnw033. Epub 2016 Apr 20.